BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 10931841)

  • 1. Direct examination of histone acetylation on Myc target genes using chromatin immunoprecipitation.
    Eberhardy SR; D'Cunha CA; Farnham PJ
    J Biol Chem; 2000 Oct; 275(43):33798-805. PubMed ID: 10931841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. c-Myc mediates activation of the cad promoter via a post-RNA polymerase II recruitment mechanism.
    Eberhardy SR; Farnham PJ
    J Biol Chem; 2001 Dec; 276(51):48562-71. PubMed ID: 11673469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. mSin3A/histone deacetylase 2- and PRMT5-containing Brg1 complex is involved in transcriptional repression of the Myc target gene cad.
    Pal S; Yun R; Datta A; Lacomis L; Erdjument-Bromage H; Kumar J; Tempst P; Sif S
    Mol Cell Biol; 2003 Nov; 23(21):7475-87. PubMed ID: 14559996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CAD, a c-Myc target gene, is not deregulated in Burkitt's lymphoma cell lines.
    Mac SM; Farnham PJ
    Mol Carcinog; 2000 Feb; 27(2):84-96. PubMed ID: 10657901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myc versus USF: discrimination at the cad gene is determined by core promoter elements.
    Boyd KE; Farnham PJ
    Mol Cell Biol; 1997 May; 17(5):2529-37. PubMed ID: 9111322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An E-box-mediated increase in cad transcription at the G1/S-phase boundary is suppressed by inhibitory c-Myc mutants.
    Miltenberger RJ; Sukow KA; Farnham PJ
    Mol Cell Biol; 1995 May; 15(5):2527-35. PubMed ID: 7739536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Start site selection at the TATA-less carbamoyl-phosphate synthase (glutamine-hydrolyzing)/aspartate carbamoyltransferase/dihydroorotase promoter.
    Kollmar R; Sukow KA; Sponagle SK; Farnham PJ
    J Biol Chem; 1994 Jan; 269(3):2252-7. PubMed ID: 7905000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. c-myc null cells misregulate cad and gadd45 but not other proposed c-Myc targets.
    Bush A; Mateyak M; Dugan K; Obaya A; Adachi S; Sedivy J; Cole M
    Genes Dev; 1998 Dec; 12(24):3797-802. PubMed ID: 9869632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MYC abrogates p53-mediated cell cycle arrest in N-(phosphonacetyl)-L-aspartate-treated cells, permitting CAD gene amplification.
    Chernova OB; Chernov MV; Ishizaka Y; Agarwal ML; Stark GR
    Mol Cell Biol; 1998 Jan; 18(1):536-45. PubMed ID: 9418900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen receptor/Sp1 complexes are required for induction of cad gene expression by 17beta-estradiol in breast cancer cells.
    Khan S; Abdelrahim M; Samudio I; Safe S
    Endocrinology; 2003 Jun; 144(6):2325-35. PubMed ID: 12746293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heat sensitivity and Sp1 activation of complex formation at the Syrian hamster carbamoyl-phosphate synthase (glutamine-hydrolyzing)/aspartate carbamoyltransferase/dihydroorotase promoter in vitro.
    Kollmar R; Lindstrom MJ; Farnham PJ
    J Biol Chem; 1992 Jan; 267(1):385-91. PubMed ID: 1346130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CAD gene sequence and the domain structure of the mammalian multifunctional protein CAD.
    Evans DR; Bein K; Guy HI; Liu X; Molina JA; Zimmermann BH
    Biochem Soc Trans; 1993 Feb; 21(1):186-91. PubMed ID: 8095469
    [No Abstract]   [Full Text] [Related]  

  • 13. A streamlined method for rapid and sensitive chromatin immunoprecipitation.
    Sikes ML; Bradshaw JM; Ivory WT; Lunsford JL; McMillan RE; Morrison CR
    J Immunol Methods; 2009 May; 344(1):58-63. PubMed ID: 19328803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding of c-Myc to chromatin mediates mitogen-induced acetylation of histone H4 and gene activation.
    Frank SR; Schroeder M; Fernandez P; Taubert S; Amati B
    Genes Dev; 2001 Aug; 15(16):2069-82. PubMed ID: 11511539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Function of the polypeptide chain segment connecting the dihydroorotase and aspartate transcarbamylase domains in the mammalian multifunctional CAD.
    Guy HI; Evans DR
    Adv Exp Med Biol; 1994; 370():729-33. PubMed ID: 7661008
    [No Abstract]   [Full Text] [Related]  

  • 16. Regulation of carbamoyl phosphate synthetase-aspartate transcarbamoylase-dihydroorotase gene expression in growing and arrested cells.
    Liao WS; Heller R; Green P; Stark GR
    J Biol Chem; 1986 Nov; 261(33):15577-81. PubMed ID: 2877980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the 5' end of the growth-regulated Syrian hamster CAD gene.
    Farnham PJ; Kollmar R
    Cell Growth Differ; 1990 Apr; 1(4):179-89. PubMed ID: 1982061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptional repression of human cad gene by hypoxia inducible factor-1alpha.
    Chen KF; Lai YY; Sun HS; Tsai SJ
    Nucleic Acids Res; 2005; 33(16):5190-8. PubMed ID: 16155188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of Myc-induced histone modifications on target chromatin.
    Martinato F; Cesaroni M; Amati B; Guccione E
    PLoS One; 2008; 3(11):e3650. PubMed ID: 18985155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomic instability and apoptosis are frequent in p53 deficient young mice.
    Fukasawa K; Wiener F; Vande Woude GF; Mai S
    Oncogene; 1997 Sep; 15(11):1295-302. PubMed ID: 9315097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.